Skip to main content

Day: March 21, 2022

authID.ai Announces 2021 Operational and Financial Results

Company Completes Financing of $22.5 MillionManagement to Host Conference Call Today at 8:30 a.m. EDT LONG BEACH, N.Y., March 21, 2022 (GLOBE NEWSWIRE) — authID.ai [Nasdaq: AUID] a leading provider of secure, mobile, biometric identity authentication, today reported financial and operating results for the year ended December 31, 2021. Since the Company’s rebrand to authID.ai in June 2021, significant progress has been made on its strategic objectives, including completing an uplisting to Nasdaq and an $11.5M investment round in August. authID also strengthened and diversified its Board of Directors and management team which has focused on promoting the Company’s brand, and innovating its Verified Identity as a Service (IDaaS) platform to enhance the user experience and drive adoption. The issuance and notice of allowance of patents...

Continue reading

BlackRock® Canada Announces March Cash Distributions for the iShares® ETFs

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the March 2022 cash distributions for the iShares ETFs listed on the TSX or NEO which pay on a monthly or quarterly basis. Unitholders of record of a fund on March 28, 2022 will receive cash distributions payable in respect of that fund on March 31, 2022. Details regarding the “per unit” distribution amounts are as follows:Fund Name FundTicker CashDistributionPer Unit ($)iShares 1-10 Year Laddered Corporate Bond Index ETF CBH 0.044iShares 1-5 Year Laddered Corporate Bond Index ETF CBO 0.037iShares S&P/TSX Canadian Dividend Aristocrats Index ETF CDZ 0.093iShares Equal Weight Banc & Lifeco ETF CEW 0.048iShares Global...

Continue reading

Life Science Instrumentation Market Size [2021-2028] | Growth, Share, Industry Trends Forecast

Life Science Instrumentation Market to Benefit from the Increasing Awareness Regarding Early Diagnosis and Treatment | Fortune Business Insights Pune, India, March 21, 2022 (GLOBE NEWSWIRE) — The global life science instrumentation market will benefit from recent advancements in the life science instrumentation industry. According to a report by Fortune Business Insights, titled “Life Science Instrumentation Market Size, Share and Global Trend By Technology (PCR, Spectroscopy, Microscopy, Chromatography, Electrophoresis, Next-generation sequencing (NGS), Flow Cytometry, Centrifuges), By Application (Clinical and Diagnostic, Research), By Distribution Channel (Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, Academic & Research institutions) and Geography Forecast till 2026,” the market will...

Continue reading

Trillium Gold Retains Market Liquidity Services

VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) — Trillium Gold Mines Inc. (TSXV: TGM) (OTCQX:TGLDF) (FRA:0702) (“Trillium Gold” or the “Company”) is pleased to announce that, subject to regulatory approval, it has retained Red Cloud Securities Inc. (“Red Cloud”) to provide market-making services to the Company in compliance with the policies and guidelines of the TSX Venture Exchange (“TSXV”) and other applicable legislation. Red Cloud, a Toronto-based registered Investment Dealer focused on providing comprehensive capital market services, will trade shares of Trillium Gold on the TSXV for the purposes of maintaining a reasonable market and improving the liquidity of Trillium Gold common shares. Under the agreement, the Company will pay Red Cloud $5,000 per month, payable quarterly in advance,...

Continue reading

Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update

Altitude Trial Dosing Expected To Be Completed in 2Q2022; mid-2022 for ILD-DLCO Trial Phase 2 Hypoxic Solid Tumor Study Protocol Submission Planned to Support 2H22 Study Start $37.3M in Cash & Cash Equivalents as of Year-End; Expected to Fund Operations Through 2023CHARLOTTESVILLE, Va., March 21, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced financial results for 2021 and provided a business update. Corporate Strategy and Events Business and financial highlights during 2021 and 2022 year-to-date include: Declared Lead Development Program: The Company announced its intent to develop its novel, oxygen...

Continue reading

Pinduoduo Announces Fourth Quarter 2021 and Fiscal Year 2021 Unaudited Financial Results

SHANGHAI, China, March 21, 2022 (GLOBE NEWSWIRE) — Pinduoduo Inc. (“Pinduoduo” or the “Company”) (NASDAQ: PDD), China’s largest agriculture and interactive commerce platform, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2021. Fourth Quarter 2021 HighlightsGMV1 in the twelve-month period ended December 31, 2021 was RMB2,441.0 billion (US$2383.0 billion), an increase of 46% from RMB1,667.6 billion in the twelve-month period ended December 31, 2020.Total revenues in the quarter were RMB27,230.9 million (US$24,273.1 million), an increase of 3% from RMB 26,547.7 million in the same quarter of 2020.Average monthly active users3 in the quarter was 733.4 million, an increase of 2% from 719.9 million in the same quarter of 2020.Active buyers4 in the twelve-month period...

Continue reading

GCM Mining Announces Subscription to Aris Gold Convertible Debenture; Next Monthly Dividend to be Paid on April 18, 2022

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — GCM Mining Corp. (“GCM Mining” or the “Company”) (TSX: GCM, OTCQX: TPRFF) announced today that it has subscribed to a US$35 million convertible senior unsecured debenture (the “Debenture”) to be issued by a wholly-owned subsidiary of Aris Gold Corporation (“Aris Gold”) (TSX: ARIS). The proceeds of the Debenture will be used to pay a portion of the purchase price for the acquisition, through a joint venture company, of a 20% ownership interest (the “Transaction”) in the Soto Norte gold project in Colombia, one of the world’s largest feasibility-stage gold projects with high-grade mineral reserves, low capital intensity, low operating costs and district-scale potential. Aris Gold will become the operator of the Soto Norte gold project and will have an option to increase its ownership to...

Continue reading

Avance Gas Holding Ltd: Sale of the VLGC Providence

Bermuda, 21 March 2022 – Avance Gas Holding Ltd (“AGAS” or the “Company”) have entered a contract to sell the 2008-built VLGC Providence with expected delivery in May. The sale is expected to generate approximately USD 24.3 million in net cash proceeds and a book profit of approximately USD 4.8 million to be recognised in the second quarter 2022. Since January 2022, the Company has sold two older VLGCs in a strong second-hand market generating approximately USD 46.8 million in total net cash proceeds. The sales follow the company’s fleet renewal strategy, reducing average age and emissions while further strengthening our balance sheet. For further queries, please contact: Randi Navdal Bekkelund, CFOTel: +47 22 00 48 29 About Avance Gas:Avance Gas operates in the global market for transportation of liquefied petroleum...

Continue reading

Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announces financial results for the fourth quarter and year ended December 31, 2021 and provides a corporate update. “We enter 2022 excited about the future for Indaptus as we continue to advance our clinical readiness with site selection, toxicology studies and other tasks necessary for the successful clearance of our Investigational New Drug application,” said Jeffrey Meckler, Chief Executive Officer of Indaptus. “With Dr. Litchev at the clinical helm, we look forward to his final evaluation of the study design and clinical strategy. We remain on track to initiate this important Phase 1 study of Decoy20 this year and look forward to bringing this novel, multi-targeted therapy to the fight...

Continue reading

Bitcoin Well Reports 2021 Financial Results and Announces Closing of Second Tranche of Secured Debenture Financing

EDMONTON, Alberta, March 21, 2022 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (the “Company” or “Bitcoin Well”) (TSXV: BTCW), today announced our financial and operating results for the fourth quarter and twelve months ended December 31, 2021 and the closing of the second tranche under the Company’s secured convertible debenture (the “Convertible Debenture”) in the principal amount of $2 million on March 17, 2022. The interim Financial Statements and Notes, as well as Management’s Discussion and Analysis (“MD&A”) are available on our website and have been filed on SEDAR. “Bitcoin Well increased revenue by 92% in 2021 as a result of the expansion of white glove service at our in-person offices in Western Canada. The next step is to expand our online ecosystem of products to eventually serve a global market,” said Adam O’Brien, Founder...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.